Annual Report 2024

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2024 150 The United Laboratories International Holdings Limited Annual Report 2024 46. INFORMATION ABOUT THE STATEMENT OF FINANCIAL POSITION OF THE COMPANY (a) Statement of financial position of the Company 2024 2023 RMB’000 RMB’000 Non-current assets Interests in subsidiaries 2,552,000 2,552,000 Right-of-use assets 2,173 3,015 Property, plant and equipment 290 184 2,554,463 2,555,199 Current assets Other receivables and prepayments 1,765 7,723 Amounts due from subsidiaries 106,847 1,550,920 Cash and cash equivalents 1,760,357 1,027,597 1,868,969 2,586,240 Current liabilities Other payables and accrued charges 11,646 8,187 Amount due to a subsidiary 196,199 196,199 Borrowings – due within one year 270,000 80,000 Derivative financial instrument – 25,587 Lease liabilities 1,394 828 Tax payables 3,639 2,243 482,878 313,044 Net current assets 1,386,091 2,273,196 Total assets less current liabilities 3,940,554 4,828,395 Non-current liabilities Derivative financial instrument – 19,191 Lease liabilities 850 2,244 850 21,435 Net assets 3,939,704 4,806,960 Capital and reserves Share capital 16,965 16,965 Reserves 3,922,739 4,789,995 Total equity 3,939,704 4,806,960